Novartis AG
NVSNYSEPharmaceutical PreparationsFiscal year ends December 31Also trades as NVSEF
$160.79−0.31 (-0.19%)
Close on Oct 30, 2026Market cap $306.81BP/E 22.5Yield –
Novartis Core Income Taxes: -$896M in Q3 2026, up 6.9% from a year earlier.
Latest, Q3 2026
-896
Period ended Sep 30, 2026
Change on a year earlier
+6.9%
-838 in Q3 2025
History
25 quarters
Since Q3 2020
Sources
21
Documents cited below
Where the Q3 2026 figure comes from
“|| Income taxes 5 | – 121 | – 168 | – 474 | – 133 | – 896 | – 838”
Source: Novartis Form 6-K (0001114448-26-000014) ↗
Reported in Form 6-K.
Quarterly history
Hover a value to see the sentence it was read from; calculated values show their formula
Cite this data
StockData. (2026). Novartis Core Income Taxes ($M), quarterly Q3 2020–Q3 2026 [Data set]. Compiled from Novartis SEC filings and investor materials. https://stockdatahq.com/stocks/nvs/kpis/core-income-taxes
See every metric in the Novartis KPI table. Data updated Nov 2, 2026.